Rationale and design of REAC-TAVI 2: Single antiplatelet treatment with ticagrelor vs aspirin after transcatheter aortic valve

Hemelrijk, KI, Jimenez-Diaz, VA, Vilchez, JP, Oteo, JF, Gomez-Blazquez, I, Sabate, M, Vilalta, V, Jofresa, AB, Asmarats, L, Amat-Santos, IJ, Tello-Montoliu, A, Hernandez, JMD, Flores, X, Gheorghe, L, Peral, V, Muñoz-Garcia, A, Alfonso, F, Tirado-Conte, G, Brugaletta, S, Veiga, G, Rodriguez-Gabella, T, Regueiro, A, de Lara, JG, del Valle-Fernandez, R, Nodar, JMR, Mazuecos, JJ, Pan, MN, Baz, JA, Fernández, JFD, Guerreiro, C, Jorge, E, Silva, MT, Marques, JS, Rodrigues, I, Neves, D, Braga, JP, Testa, L, Costa, G, Stefanini, G, Pesarini, G

DOI: 10.1016/j.ahj.2025.107293

На странице источника доступны аннотация, полный текст или сведения о том, где его прочитать.